http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104096048-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a7355b3d88d9992c7d7f1e63abc869 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
filingDate | 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102c9901f9b6d0e1585b5bea277a0d44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58d2386396b9a9ac552d72f4792b6b2f |
publicationDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104096048-A |
titleOfInvention | Quick-acting wound hemostatic anti-inflammatory analgesic powder |
abstract | The invention discloses a quick-acting wound hemostatic anti-inflammatory analgesic powder, which is prepared by: taking 18%-20% of aizoon stonecrop herb, 40%-42% of jujube tree bark, Chinese angelica 20%-22% of, and 18%-20% of paris polyphylla as raw materials, and subjecting the materials to drying, crushing, extraction and mixing to obtain the wound hemostatic anti-inflammatory analgesic powder, which has the advantages of good hemostatic, anti-inflammatory and analgesic effects, rapid wound healing promotion, no wound suppuration and infection, and especially strong hemostatic capacity. The formed scab is tightly and powerfully combined with surrounding skin, is difficult to fall off, and can prevent water soaking, thus reducing the chance of infection. And the wound surface granulation is fresh, and the epithelium grows well. The hemostatic anti-inflammatory analgesic powder provided by the invention is suitable for hemostasis, inflammation diminishing and analgesia of various wounds, and has the advantages of obvious curative effect, quick healing, no adverse reaction, and no side effect. |
priorityDate | 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 |
Total number of triples: 18.